Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Poorsina Pharmaceutical Company is a prominent Iranian pharmaceutical firm established in 1983, specializing in the manufacture of both chemical and herbal medicinal products. The company operates a comprehensive production facility in Isfahan that is GMP-certified for various dosage forms, including tablets, capsules, and oral liquids. Poorsina is recognized for its innovation in nanotechnology, particularly through the development of nanomicellar formulations for herbal extracts like curcumin to improve bioavailability. Its product portfolio spans several therapeutic areas such as endocrinology, gastroenterology, neurology, and cardiovascular health. The company aims to integrate traditional Persian medicine with modern pharmaceutical technology to provide high-quality, affordable healthcare solutions. Poorsina maintains a strong presence in the domestic Iranian market and actively engages in research and development to expand its line of proprietary herbal treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Poorsina Pharmaceutical Company.